165 related articles for article (PubMed ID: 27364549)
41. Improved rate control reduces cardiac troponin T levels in permanent atrial fibrillation.
Ulimoen SR; Enger S; Norseth J; Pripp AH; Abdelnoor M; Arnesen H; Gjesdal K; Tveit A
Clin Cardiol; 2014 Jul; 37(7):422-7. PubMed ID: 24700386
[TBL] [Abstract][Full Text] [Related]
42. Changes in heart rate variability are correlated to hemodynamic improvement with chronic CARVEDILOL therapy in heart failure.
Bullinga JR; Alharethi R; Schram MS; Bristow MR; Gilbert EM
J Card Fail; 2005 Dec; 11(9):693-9. PubMed ID: 16360965
[TBL] [Abstract][Full Text] [Related]
43. Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN).
Komajda M; Lutiger B; Madeira H; Thygesen K; Bobbio M; Hildebrandt P; Jaarsma W; Riegger G; Rydén L; Scherhag A; Soler-Soler J; Remme WJ;
Eur J Heart Fail; 2004 Jun; 6(4):467-75. PubMed ID: 15182773
[TBL] [Abstract][Full Text] [Related]
44. Antiadrenergic therapy in the control of atrial fibrillation.
Naccarelli GV
J Cardiovasc Pharmacol Ther; 2005 Jun; 10 Suppl 1():S33-43. PubMed ID: 15965571
[TBL] [Abstract][Full Text] [Related]
45. Efficacy of carvedilol on complex ventricular arrhythmias in dilated cardiomyopathy: double-blind, randomized, placebo-controlled study.
Cice G; Tagliamonte E; Ferrara L; Iacono A
Eur Heart J; 2000 Aug; 21(15):1259-64. PubMed ID: 10924316
[TBL] [Abstract][Full Text] [Related]
46. The effect of low dose carvedilol on circadian variation of blood pressure in patients with essential hypertension.
Ogihara T; Ikeda M; Goto Y; Yoshinaga K; Kumahara Y; Iimura O; Ishii M; Murakami E; Takeda T; Kokubu T
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S108-12. PubMed ID: 2454355
[TBL] [Abstract][Full Text] [Related]
47. Effect of carvedilol on reduction in heart rate in patients with chronic atrial fibrillation.
Kodani E; Matsumoto S; Igawa O; Kusama Y; Atarashi H
J Clin Med Res; 2013 Dec; 5(6):451-9. PubMed ID: 24171057
[TBL] [Abstract][Full Text] [Related]
48. Safety and tolerability of once-daily controlled-release carvedilol 10-80 mg in Japanese patients with chronic heart failure.
Kitakaze M; Sarai N; Ando H; Sakamoto T; Nakajima H
Circ J; 2012; 76(3):668-74. PubMed ID: 22240593
[TBL] [Abstract][Full Text] [Related]
49. Effect of metoprolol versus carvedilol on outcomes in MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy).
Ruwald MH; Ruwald AC; Jons C; Alexis J; McNitt S; Zareba W; Moss AJ
J Am Coll Cardiol; 2013 Apr; 61(14):1518-26. PubMed ID: 23500269
[TBL] [Abstract][Full Text] [Related]
50. Comparative dose titration responses to the introduction of bisoprolol or carvedilol in stable chronic systolic heart failure.
Hamaad A; Lip GY; Nicholls D; MacFadyen RJ
Cardiovasc Drugs Ther; 2007 Dec; 21(6):437-44. PubMed ID: 17896170
[TBL] [Abstract][Full Text] [Related]
51. Does atrial fibrillation in very elderly patients with chronic systolic heart failure limit the use of carvedilol?
Cioffi G; De Feo S; Pulignano G; Del Sindaco D; Tarantini L; Stefenelli C; Opasich C
Int J Cardiol; 2006 Feb; 107(2):220-4. PubMed ID: 16412800
[TBL] [Abstract][Full Text] [Related]
52. Beneficial effect of carvedilol on heart rate response to exercise in digitalised patients with heart failure in atrial fibrillation due to idiopathic dilated cardiomyopathy.
Agarwal AK; Venugopalan P
Eur J Heart Fail; 2001 Aug; 3(4):437-40. PubMed ID: 11511429
[TBL] [Abstract][Full Text] [Related]
53. Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial).
Di Lenarda A; Remme WJ; Charlesworth A; Cleland JG; Lutiger B; Metra M; Komajda M; Torp-Pedersen C; Scherhag A; Swedberg K; Poole-Wilson PA;
Eur J Heart Fail; 2005 Jun; 7(4):640-9. PubMed ID: 15921806
[TBL] [Abstract][Full Text] [Related]
54. Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database.
Paolillo S; Mapelli M; Bonomi A; Corrà U; Piepoli M; Veglia F; Salvioni E; Gentile P; Lagioia R; Metra M; Limongelli G; Sinagra G; Cattadori G; Scardovi AB; Carubelli V; Scrutino D; Badagliacca R; Raimondo R; Emdin M; Magrì D; Correale M; Parati G; Caravita S; Spadafora E; Re F; Cicoira M; Frigerio M; Bussotti M; Minà C; Oliva F; Battaia E; Belardinelli R; Mezzani A; Pastormerlo L; Di Lenarda A; Passino C; Sciomer S; Iorio A; Zambon E; Guazzi M; Pacileo G; Ricci R; Contini M; Apostolo A; Palermo P; Clemenza F; Marchese G; Binno S; Lombardi C; Passantino A; Perrone Filardi P; Agostoni P
Eur J Heart Fail; 2017 Jul; 19(7):904-914. PubMed ID: 28233458
[TBL] [Abstract][Full Text] [Related]
55. Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study.
Davy JM; Herold M; Hoglund C; Timmermans A; Alings A; Radzik D; Van Kempen L;
Am Heart J; 2008 Sep; 156(3):527.e1-9. PubMed ID: 18760136
[TBL] [Abstract][Full Text] [Related]
56. Relation of dose of carvedilol to reduction in QT dispersion in patients with mild to moderate heart failure secondary to ischemic or to idiopathic dilated cardiomyopathy.
Pittenger B; Gill EA; Holcslaw TL; Bristow MR
Am J Cardiol; 2004 Dec; 94(11):1459-62. PubMed ID: 15566928
[TBL] [Abstract][Full Text] [Related]
57. Dose-response effects of bepridil in patients with persistent atrial fibrillation monitored with transtelephonic electrocardiograms: a multicenter, randomized, placebo-controlled,double-blind study (J-BAF Study).
Yamashita T; Ogawa S; Sato T; Aizawa Y; Atarashi H; Fujiki A; Inoue H; Ito M; Katoh T; Kobayashi Y; Koretsune Y; Kumagai K; Niwano S; Okazaki O; Okumura K; Saku K; Tanabe T; Origasa H;
Circ J; 2009 Jun; 73(6):1020-7. PubMed ID: 19359813
[TBL] [Abstract][Full Text] [Related]
58. Comparison of the efficacy of metoprolol and carvedilol for preventing atrial fibrillation after coronary bypass surgery.
Acikel S; Bozbas H; Gultekin B; Aydinalp A; Saritas B; Bal U; Yildirir A; Muderrisoglu H; Sezgin A; Ozin B
Int J Cardiol; 2008 May; 126(1):108-13. PubMed ID: 17499863
[TBL] [Abstract][Full Text] [Related]
59. Role of carvedilol in atrial fibrillation: insights from clinical trials.
Gheorghiade M; Lukas MA
Am J Cardiol; 2004 May; 93(9A):53B-7B. PubMed ID: 15144939
[TBL] [Abstract][Full Text] [Related]
60. Dose-effect relationship of carvedilol in essential hypertension. An open study.
Ogihara T; Goto Y; Yoshinaga K; Kumahara Y; Iimura O; Ishii M; Murakami E; Takeda T; Kokubu T; Arakawa K
Drugs; 1988; 36 Suppl 6():75-81. PubMed ID: 2908305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
